Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based united states population

Frontiers in Oncology

Volumn 4 FEB, Issue , 2014, Pages

  Hernandez, Brenda Y ^a   Goodman, Marc T ^a   Unger, Elizabeth R ^b   Steinau, Martin ^b   Powers, Amy ^a   Lynch, Charles F ^c   Cozen, Wendy ^d   Saber, Maria Sibug ^d   Peters, Edward S ^e   Wilkinson, Edward J ^f   Copeland, Glenn ^g   Hopenhayn, Claudia ^h   Huang, Youjie ⁱ   Watson, Meg ^j   Altekruse, Sean F ^k   Lyu, Christopher ^l   Saraiya, Mona ^j   Scarbrough, Mariela Z ^b   Thompson, Trevor ^j   Datta, Deblina ^m   Hariri, Susan ^m   Ellis, Bruce ^l   Madero, Natalie ^l   Reid, Emily ^l   Little, Donna ^l   Greek, April ^l   Rhoda, Dale ^l   Brossoie, Susan ⁿ   Gideon, Katherine ^l   Gieseke, Linda Delma ^l   Ashcraft, Stephanie ^l   MacKinnon, Jill ^o   Alvarez, Carlos ^o   Wilkinson, Edward ^p   Campbell Thompson, Martha ^p   Wright, Amy ^p   Durden, Kelley ^p   Hernandez, Brenda ^a   Goodman, Marc ^a   Luk, Hugh ^a   Horio, David ^a   Ikeda, Shoji ^a   Green, Michael ^a   Grafel Anderson, Catherine ^a   Weise, Rayna ^a   Selk, Freda ^c   Olson, Dan ^c   Tucker, Thomas ^h   Christian, Amy ^h   Peters, Edward ^q   Cole, Lauren ^q   Ruhlen, Tara ^r   House, Joe ^s   Cockburn, Myles G ^s   Kim, Andre ^s   Ashley, Lana ^t   Alverson, Jetty ^t   Hulbert, Michelle ^t   Silva, Won ^t   Hirsch, Samuel ^t   more..

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^h UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

ⁱ FLORIDA DEPARTMENT OF HEALTH   (United States)

^j NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^k NATIONAL CANCER INSTITUTE   (United States)

^l BATTELLE MEMORIAL INSTITUTE   (United States)

^m Division of STD Prevention   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^o UNIVERSITY OF MIAMI   (United States)

^p UNIVERSITY OF FLORIDA   (United States)

^q LOUISIANA STATE UNIVERSITY   (United States)

^r Carolinas Rehabilitation   (United States)

^s UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^t ST JOSEPH MERCY HOSPITAL   (United States)

more..

Author keywords

HPV; Human papillomavirus; Penile cancer; Prevalence; United states

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; ETHNICITY; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PENIS CANCER; POLYMERASE CHAIN REACTION; PREVALENCE; RACE; RISK FACTOR; UNITED STATES;

EID: 84898657999     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00009     Document Type: Article

References (38)

1. Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer (2008) 113(10 Suppl):2883-91. doi: 10.1002/cncr.23743
2. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control (2009) 20(4):449-57. doi:10.1007/s10552-008-9276-9
3. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine (2006) 24(Suppl 3):S3/11-25. doi:10.1016/j.vaccine.2006.05.111
4. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 159(4):1211-8. doi:10.1016/S0002-9440(10)62506-0
5. Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, de Sanjose S. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol (2009) 62(10):870-8. doi:10.1136/jcp.2008.063149
6. Lont AP, Kroon BK, Horenblas S, Gallee MP, Berkhof J, Meijer CJ, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer (2006) 119(5):1078-81. doi:10.1002/ijc.21961
7. Chaux A, Netto GJ, Rodríguez IM, Barreto JE, Oertell J, Ocampos S, et al. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol (2011) 31(4):861-7. doi:10.1007/s00345-011-0802-0
8. Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 85(1):19-24. doi:10.1093/jnci/85.1.19
9. Brinton LA, Li JY, Rong SD, Huang S, Xiao BS, Shi BG, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer (1991) 47(4):504-9. doi:10.1002/ijc.2910470406
10. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 116(4):606-16. doi:10.1002/ijc.21009
11. Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control (2001) 12(3):267-77. doi:10.1023/A:1011266405062
12. Cupp MR, Malek RS, Goellner JR, Smith TF, Espy MJ. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol (1995) 154(3):1024-9. doi:10.1016/S0022-5347(01)66967-2
13. Varma VA, Sanchez-Lanier M, Unger ER, Clark C, Tickman R, Hewan-Lowe K, et al. Association of human papillomavirus with penile carcinoma: a study using polymerase chain reaction and in situ hybridization. Hum Pathol (1991) 22(9):908-13. doi:10.1016/0046-8177(91)90181-N
14. Wiener JS, Effert PJ, Humphrey PA, Yu L, Liu ET, Walther PJ. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer (1992) 50(5):694-701. doi:10.1002/ijc.2910500505
15. Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 61(5):1934-40.
16. Gargano JW, Wilkinson EJ, Unger ER, Steinau M, Watson M, Huang Y, et al. Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 16(4):471-9. doi:10.1097/LGT.0b013e3182472947
17. Fritz A, Percy C, Shanmugaratnam K, et al. The International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization (2000).
18. Goodman MT, Hernandez BY, Hewitt S, Lynch CF, Coté TR, Frierson HF Jr, et al. Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol (2005) 36(7):812-20. doi:10.1016/j.humpath.2005.03.010
19. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2011) 13(4):377-81. doi:10.1016/j.jmoldx.2011.03.007
20. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA editors. SEER Summary Staging Manual -2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute (2001).
21. IARC. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (2007) 90:1-636.
22. Senba M, Kumatori A, Fujita S, Jutavijittum P, Yousukh A, Moriuchi T, et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol (2006) 78(10):1341-6. doi:10.1002/jmv.20703
23. Heideman DA, Waterboer T, Pawlita M, Delis-van Diemen P, Nindl I, Leijte JA, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol (2007) 25(29):4550-6. doi:10.1200/JCO.2007.12.3182
24. Guimerà N, Lloveras B, Lindeman J, Alemany L, van deSandtM, Alejo M, et al. The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am J Surg Pathol (2013) 37(9):1299-310. doi:10.1097/PAS.0b013e31828b6be4
25. Goodman MT, Hernandez BY, Shvetsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev (2007) 16(9):1833-9. doi:10.1158/1055-9965.EPI-07-0221
26. Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Guiliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol (2007) 25(5):361-7. doi:10.1016/j.urolonc.2006.08.029
27. From the Centers for Disease Control and Prevention. Cigarette smoking among adults -United States, 1991. JAMA (1993) 269(15):1931.
28. Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis (2007) 34(7):479-84.
29. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus (HPV) and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 29(32):4294-301. doi:10.1200/JCO.2011.36.4596
30. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 363(1):24-35. doi:10.1056/NEJMoa0912217
31. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer (2000) 89(3):300-4. doi:10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G
32. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 104(3):336-44. doi:10.1002/ijc.10960
33. Li W, Thompson CH, O'Brien CJ, McNeil EB, Scolyer RA, Cossart YE, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer (2003) 106(4):553-8. doi:10.1002/ijc.11261
34. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 100(4):261-9. doi:10.1093/jnci/djn011
35. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 26(19):3128-37. doi:10.1200/JCO.2007.12.7662
36. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol (2006) 24(36):5630-6. doi:10.1200/JCO.2005.04.6136
37. Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, et al. Value of p16(INK)(4)(a) in the pathology of invasive penile squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol (2011) 35(2):253-61. doi:10.1097/PAS.0b013e318203cdba
38. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med (2011) 364(5):401-11. doi:10.1056/NEJMoa0909537